Natural Capsules shareholders have approved a preferential allotment of equity shares and convertible warrants to its promoter group. The company’s Extraordinary General Meeting (EGM) held on September 9, 2026, passed both special resolutions with overwhelming support from investors.

The vote follows the dispatch of a corrigendum on September 2, 2026, which revised pricing and quantity details for the issue after queries from the BSE and NSE. The revised terms align with a valuation report dated August 31, 2026, issued by a registered valuer in compliance with Chapter V of the SEBI (ICDR) Regulations, 2018.

Voting Results

The scrutinizer’s report indicates that remote e-voting commenced on September 4, 2026, and concluded on September 8, 2026. The final results were unblocked on September 9, 2026, following the conclusion of the meeting conducted via Video Conferencing.

Both resolutions were passed with the requisite majority under Section 108 of the Companies Act, 2013. A total of 37 members participated in the voting process.

Meeting Proceedings

Mr. Tekkar Yashwanth Prabhu, Independent Director and Chairman of the company, chaired the proceedings. A quorum of 31 members attended the EGM through Video Conferencing or Other Audio Visual Means. Mr. Sunil L Mundra, Managing Director, made remarks regarding the Preferential Issue. Mr. Akshay Dutta, Company Secretary and Compliance Officer, read the Notice. Members were given the opportunity to ask questions, which the Managing Director addressed. The meeting concluded at 12:35 pm after being open for 15 minutes for e-voting.

Revised Issue Details

The approved preferential issue comprises two components: equity shares and convertible warrants, both priced at ₹178 per unit. The total value of the equity share component is ₹2,00,25,000, while the warrant component totals ₹8,01,00,000.

The equity shares have a face value of ₹10 each. The warrants are convertible into one fully paid-up equity share of face value ₹10 each.

Warrant Terms and Conditions

The convertible warrants carry specific payment and conversion terms. Investors must pay 25% of the warrant exercise price (₹44.50) at the time of subscription and allotment. The remaining 75% is payable upon exercising the option to subscribe to equity shares.

Key terms include:

• Conversion period: 18 months from the date of allotment.
• Forfeiture: If warrants lapse within the 18-month window, the company forfeits the initial 25% payment.
• Adjustment: Amounts paid against warrants will be adjusted against the issue price for resultant equity shares.

Shareholding Impact

The allotment is targeted at Mr. Sunil L Mundra, a member of the promoter group. Currently, he holds 6,02,290 shares, representing 5.79% of the total equity.

Upon full conversion of warrants and allotment of equity shares, his holding would increase to 11,64,790 shares, or 10.61% of the post-issue capital. This calculation assumes full subscription and conversion based on shareholding as on August 10, 2026.

Natural Capsules Limited has set September 2, 2026 as the record date for its Extraordinary General Meeting (EGM) scheduled for September 9, 2026. Shareholders on record as of this date will be eligible to vote on the proposed ₹10 crore preferential allotment. The capital raise aims to strengthen working capital requirements and fund capital expansion, including the acquisition or establishment of new units.

The Board of Directors approved the proposal on August 12, 2026. The issue is structured into two components: equity shares and convertible warrants, both priced at ₹160 per unit. Promoter Sunil Laxminarayan Mundra is the sole proposed allottee for the entire tranche.

Issue Structure

The total raise of ₹10 crore is divided as follows:

The equity shares will be fully paid-up at the time of allotment. The warrants are fully convertible into equity shares on a one-to-one basis within 18 months of allotment.

Warrant Terms

The warrant structure requires an upfront payment of ₹40 (25% of the issue price) at subscription. The remaining ₹120 (75%) is payable upon exercise of the conversion right. If the warrants are not exercised within the 18-month tenure, the entitlement expires, and the upfront amount paid stands forfeited by the company. The warrants do not carry voting rights until converted.

Shareholding Impact

As of June 30, 2026, promoters held 50.92% of the company’s equity. Post-issue, assuming full conversion of warrants, promoter holding is projected to rise to 53.70%. Sunil Laxminarayan Mundra’s individual stake is expected to increase from 5.79% to 11.12%.